330 related articles for article (PubMed ID: 17539695)
1. Implementation of monitoring and management guidelines for second-generation antipsychotics.
Sernyak MJ
J Clin Psychiatry; 2007; 68 Suppl 4():14-8. PubMed ID: 17539695
[TBL] [Abstract][Full Text] [Related]
2. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
3. Bridging the gap between mental and physical health: a multidisciplinary approach.
Vreeland B
J Clin Psychiatry; 2007; 68 Suppl 4():26-33. PubMed ID: 17539697
[TBL] [Abstract][Full Text] [Related]
4. Metabolic and endocrine disturbances in psychiatric disorders: a multidisciplinary approach to appropriate atypical antipsychotic utilization.
Masand PS; Culpepper L; Henderson D; Lee S; Littrell K; Newcomer JW; Rasgon N
CNS Spectr; 2005 Oct; 10(10):suppl14 1-15. PubMed ID: 16404802
[TBL] [Abstract][Full Text] [Related]
5. Integrating general health care in private community psychiatry practice.
Goff DC
J Clin Psychiatry; 2007; 68 Suppl 4():49-54. PubMed ID: 17539701
[TBL] [Abstract][Full Text] [Related]
6. Primary care issues in patients with mental illness.
Kiraly B; Gunning K; Leiser J
Am Fam Physician; 2008 Aug; 78(3):355-62. PubMed ID: 18711951
[TBL] [Abstract][Full Text] [Related]
7. Schizophrenia and comorbid metabolic disorders.
Henderson DC
J Clin Psychiatry; 2005; 66 Suppl 6():11-20. PubMed ID: 16107179
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic medications: metabolic and cardiovascular risk.
Newcomer JW
J Clin Psychiatry; 2007; 68 Suppl 4():8-13. PubMed ID: 17539694
[TBL] [Abstract][Full Text] [Related]
9. Metabolic abnormalities associated with second generation antipsychotics: fact or fiction? Development of guidelines for screening and monitoring.
De Hert M; van Eyck D; De Nayer A
Int Clin Psychopharmacol; 2006 Mar; 21 Suppl 2():S11-5. PubMed ID: 16601508
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome and associated cardiovascular risk factors in the treatment of persons with human immunodeficiency virus and severe mental illness.
Vergara-Rodriguez P; Vibhakar S; Watts J
Pharmacol Ther; 2009 Dec; 124(3):269-78. PubMed ID: 19647020
[TBL] [Abstract][Full Text] [Related]
11. Metabolic considerations in the use of antipsychotic medications: a review of recent evidence.
Newcomer JW
J Clin Psychiatry; 2007; 68 Suppl 1():20-7. PubMed ID: 17286524
[TBL] [Abstract][Full Text] [Related]
12. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
Wheeler AJ
Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
[TBL] [Abstract][Full Text] [Related]
13. [Atypical antipsychotic induced weight gain and metabolic disorders].
Rojas G P; Poblete A C; Orellana G X; Rouliez A K; Liberman G C
Rev Med Chil; 2009 Jan; 137(1):106-14. PubMed ID: 19399331
[TBL] [Abstract][Full Text] [Related]
14. Tolerability of antipsychotics: recent controversies and future management.
Fleischhacker WW
J Clin Psychiatry; 2009 Mar; 70(3):e06. PubMed ID: 19317956
[TBL] [Abstract][Full Text] [Related]
15. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
16. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
[TBL] [Abstract][Full Text] [Related]
17. Schizophrenia and obesity: impact of antipsychotic medications.
Wirshing DA
J Clin Psychiatry; 2004; 65 Suppl 18():13-26. PubMed ID: 15600381
[TBL] [Abstract][Full Text] [Related]
18. Obesity and metabolic syndrome in a psychiatric rehabilitation service.
Tirupati S; Chua LE
Aust N Z J Psychiatry; 2007 Jul; 41(7):606-10. PubMed ID: 17558623
[TBL] [Abstract][Full Text] [Related]
19. Long-term health considerations in schizophrenia: metabolic effects and the role of abdominal adiposity.
Van Gaal LF
Eur Neuropsychopharmacol; 2006 Sep; 16 Suppl 3():S142-8. PubMed ID: 16863690
[TBL] [Abstract][Full Text] [Related]
20. Physical health and schizophrenia.
Mitchell AJ; Malone D
Curr Opin Psychiatry; 2006 Jul; 19(4):432-7. PubMed ID: 16721177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]